Chemical Component Summary

Name4-{2-[4-(3,10-DIBROMO-8-CHLORO-6,11-DIHYDRO-5H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDIN-11-YL)PIPERIDIN-1-YL]-2-OXOETHYL}PIPERIDINE-1-CARBOXAMIDE
Identifiers
FormulaC27 H31 Br2 Cl N4 O2
Molecular Weight638.82
TypeNON-POLYMER
Isomeric SMILESNC(=O)N1CCC(CC1)CC(=O)N2CCC(CC2)[C@H]3c4ncc(Br)cc4CCc5cc(Cl)cc(Br)c35
InChIInChI=1S/C27H31Br2ClN4O2/c28-20-12-19-2-1-18-13-21(30)14-22(29)24(18)25(26(19)32-15-20)17-5-9-33(10-6-17)23(35)11-16-3-7-34(8-4-16)27(31)36/h12-17,25H,1-11H2,(H2,31,36)/t25-/m1/s1
InChIKeyDHMTURDWPRKSOA-RUZDIDTESA-N

Chemical Details

Formal Charge0
Atom Count67
Chiral Atom Count1
Bond Count71
Aromatic Bond Count12

Drug Info: DrugBank

DrugBank IDDB06448 
NameLonafarnib
Groupsinvestigational
Synonyms
  • Lonafarnibum
  • Lonafarnib
IndicationInvestigated for use/treatment in solid tumors, leukemia (unspecified), and lung cancer.
Categories
  • Enzyme Inhibitors
  • P-glycoprotein inhibitors
CAS number193275-84-2

Drug Targets

NameTarget SequencePharmacological ActionActions
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaMAATEGVGEAAQGGEPGQPAQPPPQPHPPPPQQQHKEEMAAEAGEAVASP...unknown
Insulin-like growth factor-binding protein 3MQRARPTLWAAALTLLVLLRGPPVARAGASSAGLGPVVRCEPCDARALAQ...unknown
P-glycoprotein 1MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...unknowninhibitor
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682